Pembrolizumab and Decitabine for Refractory or Relapsed Acute Myeloid Leukemia
Meghali Goswami, Gege Gui, Laura W. Dillon, Katherine E. Lindblad, Julie Thompson, Janet Valdez, Dong-Yun Kim, Jack Y. Ghannam, Karolyn A. Oetjen, Christin B. Destefano, Dana M. Smith, Hanna Tekleab, Yuesheng Li, Pradeep K. Dagur, Thomas Hughes, Jennifer L. Marte, Jaydira del Rivero, Joanna Klubo-Gwiezdzinksa, James L. Gulley, Katherine R. Calvo, Catherine Lai, Christopher S. Hourigan
doi: https://doi.org/10.1101/2021.06.23.21258377
Meghali Goswami
1National Heart, Lung, and Blood Institute; National Institutes of Health, Bethesda, MD 20892, USA
2Laboratory of Tumor Immunology and Biology; National Cancer Institute; National Institutes of Health, Bethesda, MD 20892, USA
Gege Gui
1National Heart, Lung, and Blood Institute; National Institutes of Health, Bethesda, MD 20892, USA
Laura W. Dillon
1National Heart, Lung, and Blood Institute; National Institutes of Health, Bethesda, MD 20892, USA
Katherine E. Lindblad
1National Heart, Lung, and Blood Institute; National Institutes of Health, Bethesda, MD 20892, USA
Julie Thompson
1National Heart, Lung, and Blood Institute; National Institutes of Health, Bethesda, MD 20892, USA
Janet Valdez
1National Heart, Lung, and Blood Institute; National Institutes of Health, Bethesda, MD 20892, USA
Dong-Yun Kim
1National Heart, Lung, and Blood Institute; National Institutes of Health, Bethesda, MD 20892, USA
Jack Y. Ghannam
1National Heart, Lung, and Blood Institute; National Institutes of Health, Bethesda, MD 20892, USA
Karolyn A. Oetjen
1National Heart, Lung, and Blood Institute; National Institutes of Health, Bethesda, MD 20892, USA
Christin B. Destefano
1National Heart, Lung, and Blood Institute; National Institutes of Health, Bethesda, MD 20892, USA
Dana M. Smith
Hanna Tekleab
1National Heart, Lung, and Blood Institute; National Institutes of Health, Bethesda, MD 20892, USA
Yuesheng Li
1National Heart, Lung, and Blood Institute; National Institutes of Health, Bethesda, MD 20892, USA
Pradeep K. Dagur
1National Heart, Lung, and Blood Institute; National Institutes of Health, Bethesda, MD 20892, USA
Thomas Hughes
4National Institutes of Health Clinical Center; Bethesda, MD 20892; USA
Jennifer L. Marte
5National Cancer Institute; National Institutes of Health, Bethesda, MD 20892, USA
Jaydira del Rivero
5National Cancer Institute; National Institutes of Health, Bethesda, MD 20892, USA
Joanna Klubo-Gwiezdzinksa
6National Institute of Diabetes and Digestive and Kidney Diseases; National Institutes of Health, Bethesda, MD 20892, USA
James L. Gulley
5National Cancer Institute; National Institutes of Health, Bethesda, MD 20892, USA
Katherine R. Calvo
4National Institutes of Health Clinical Center; Bethesda, MD 20892; USA
Catherine Lai
1National Heart, Lung, and Blood Institute; National Institutes of Health, Bethesda, MD 20892, USA
Christopher S. Hourigan
1National Heart, Lung, and Blood Institute; National Institutes of Health, Bethesda, MD 20892, USA
Posted June 25, 2021.
Pembrolizumab and Decitabine for Refractory or Relapsed Acute Myeloid Leukemia
Meghali Goswami, Gege Gui, Laura W. Dillon, Katherine E. Lindblad, Julie Thompson, Janet Valdez, Dong-Yun Kim, Jack Y. Ghannam, Karolyn A. Oetjen, Christin B. Destefano, Dana M. Smith, Hanna Tekleab, Yuesheng Li, Pradeep K. Dagur, Thomas Hughes, Jennifer L. Marte, Jaydira del Rivero, Joanna Klubo-Gwiezdzinksa, James L. Gulley, Katherine R. Calvo, Catherine Lai, Christopher S. Hourigan
medRxiv 2021.06.23.21258377; doi: https://doi.org/10.1101/2021.06.23.21258377
Pembrolizumab and Decitabine for Refractory or Relapsed Acute Myeloid Leukemia
Meghali Goswami, Gege Gui, Laura W. Dillon, Katherine E. Lindblad, Julie Thompson, Janet Valdez, Dong-Yun Kim, Jack Y. Ghannam, Karolyn A. Oetjen, Christin B. Destefano, Dana M. Smith, Hanna Tekleab, Yuesheng Li, Pradeep K. Dagur, Thomas Hughes, Jennifer L. Marte, Jaydira del Rivero, Joanna Klubo-Gwiezdzinksa, James L. Gulley, Katherine R. Calvo, Catherine Lai, Christopher S. Hourigan
medRxiv 2021.06.23.21258377; doi: https://doi.org/10.1101/2021.06.23.21258377
Subject Area
Subject Areas
- Addiction Medicine (313)
- Allergy and Immunology (616)
- Anesthesia (158)
- Cardiovascular Medicine (2257)
- Dermatology (201)
- Emergency Medicine (368)
- Epidemiology (11549)
- Forensic Medicine (10)
- Gastroenterology (676)
- Genetic and Genomic Medicine (3541)
- Geriatric Medicine (336)
- Health Economics (612)
- Health Informatics (2287)
- Health Policy (910)
- Hematology (333)
- HIV/AIDS (742)
- Medical Education (357)
- Medical Ethics (100)
- Nephrology (385)
- Neurology (3326)
- Nursing (190)
- Nutrition (504)
- Oncology (1748)
- Ophthalmology (522)
- Orthopedics (208)
- Otolaryngology (283)
- Pain Medicine (222)
- Palliative Medicine (66)
- Pathology (435)
- Pediatrics (998)
- Primary Care Research (399)
- Public and Global Health (5974)
- Radiology and Imaging (1216)
- Respiratory Medicine (807)
- Rheumatology (367)
- Sports Medicine (311)
- Surgery (383)
- Toxicology (50)
- Transplantation (170)
- Urology (142)